Conference Proceedings

Additional Courses of Alemtuzumab Improved Clinical and MRI Outcomes in Pooled CARE-MS I and II Patients With Disease Activity After Two Courses: Analysis of Patients Who Received >= 3 Courses

HJ Kim, A Traboulsee, AD Bass, A Boster, R Berkovich, G Comi, O Fernandez, V Limmroth, J Lycke, RAL Macdonell, S Schippling, P Vermersch, H Wiendl, T Ziemssen, L Chung, N Daizadeh, CE Rodriguez, BA Singer

MULTIPLE SCLEROSIS JOURNAL | SAGE PUBLICATIONS LTD | Published : 2019

University of Melbourne Researchers

Grants

Funding Acknowledgements

Sanofi and Bayer HealthCare Pharmaceuticals.